IRF7 and melanoma: Moreover, we detected a considerable inhibition of IRF7 constitutive expression in pDCs after their exposure to SN-mel (Figure 6E), providing evidence that TLR/MyD88-dependent signaling in pDCs was inhibited by melanoma secretome.